NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Tyme Technologies Inc (F: RFL)

 
RFL Technical Analysis
5
As on 16th Sep 2022 RFL STOCK Price closed @ 0.32 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.84 & Strong Sell for SHORT-TERM with Stoploss of 1.19 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RFLSTOCK Price

Open 0.32 Change Price %
High 0.32 1 Day 0.04 14.29
Low 0.32 1 Week 0.09 39.13
Close 0.32 1 Month 0.00 0.00
Volume N/A 1 Year -1.10 -77.46
52 Week High 1.47 | 52 Week Low 0.20
 
F Germany Most Active Stocks
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
WDI 0.05 -37.50%
TOE 0.02 0.00%
 
F Germany Top Gainers Stocks
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
WPIA 6.22 871.88%
8S3B 1.73 620.83%
8S3B 1.73 620.83%
SY7P 0.07 600.00%
P9F1 1.75 326.83%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
LDB 1.71 -92.57%
AETG 0.25 -91.61%
AETG 0.25 -91.61%
 
 
RFL
Daily Charts
RFL
Intraday Charts
Whats New @
Bazaartrend
RFL
Free Analysis
 
RFL Important Levels Intraday
RESISTANCE0.32
RESISTANCE0.32
RESISTANCE0.32
RESISTANCE0.32
RESISTANCE0.32
RESISTANCE0.32
RESISTANCE0.32
RESISTANCE0.32
 
RFL Forecast May 2024
4th UP Forecast1.23
3rd UP Forecast0.94
2nd UP Forecast0.76
1st UP Forecast0.58
1st DOWN Forecast0.06
2nd DOWN Forecast-0.12
3rd DOWN Forecast-0.3
4th DOWN Forecast-0.59
 
RFL Weekly Forecast
4th UP Forecast0.72
3rd UP Forecast0.59
2nd UP Forecast0.51
1st UP Forecast0.43
1st DOWN Forecast0.21
2nd DOWN Forecast0.13
3rd DOWN Forecast0.05
4th DOWN Forecast-0.08
 
RFL Forecast2024
4th UP Forecast2.83
3rd UP Forecast2.02
2nd UP Forecast1.53
1st UP Forecast1.03
1st DOWN Forecast-0.39
2nd DOWN Forecast-0.89
3rd DOWN Forecast-1.38
4th DOWN Forecast-2.19
 
 
RFL Other Details
Segment EQ
Market Capital 139519264.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
RFL Address
RFL
 
RFL Latest News
 
Your Comments and Response on Tyme Technologies Inc
 
RFL Business Profile
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma. The company also offers TYME-19, an oral synthetically produced member of the bile acid family, which is in preclinical stage for the treatment of COVID-19 and disease variants; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; NYU School of Medicine to examine multiple aspects of SM-88 mechanisms; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey. Address: 1 Pluckemin Way, Bedminster, NJ, United States, 07921
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service